Ledger.Open graph →
SEC Form D · filed June 2, 2025

Immunomic Therapeutics, Inc

Offering
$16.0M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ROCKVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Steve E. Park · ROCKVILLE, MDDirectorJames W. Wishart · ROCKVILLE, MDDirectorMatthew E. Chang · ROCKVILLE, MDDirectorYang Gon E. Jin · ROCKVILLE, MDDirectorRobert E. Ahlgren · ROCKVILLE, MDDirectorDong-Gun Kim · ROCKVILLE, MDExec · DirectorKi-Hong E. Ahn · ROCKVILLE, MDDirectorMatthew E. Chang · ROCKVILLE, MDDirectorSteve E. Park · ROCKVILLE, MDDirectorRobert E. Ahlgren · ROCKVILLE, MDDirectorKi-Hong E. Ahn · ROCKVILLE, MDDirectorPatrick Puzzuoli · New York, NYDirectorYang Gon E. Jin · ROCKVILLE, MDDirectorDong-Gun Kim · ROCKVILLE, MDExec · DirectorLeise N. Rosman · Phoenix, AZDirectorPeter Jonna · San Diego, CAExec · DirectorChristiian Marriott · London, United KingdomDirectorStorage Units Capital Management II Corporation · Maitland, FLDirectorStorage Units Ground Lease Management Corporation · Maitland, FLDirectorFarooq Cheema · Virginia Beach, VADirectorMarion D. Broch · Luxembourg, LuxembourgDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗